tiprankstipranks
Fennec Pharmaceuticals (TSE:FRX)
TSX:FRX
Holding TSE:FRX?
Track your performance easily

Fennec Pharmaceuticals (FRX) Financial Statements

15 Followers

Fennec Pharmaceuticals Financial Overview

Fennec Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.143; its P/E ratio is -59.72; Fennec Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is C$0.23. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 6.97M$ 7.26M$ 27.51M$ 9.73M$ 6.51M
Gross Profit$ 5.62M$ 6.65M$ 24.83M$ 9.05M$ 6.18M
EBIT$ -4.71M$ -4.51M$ 13.87M$ -1.77M$ -1.01M
EBITDA$ -4.69M$ -4.49M$ 13.89M$ -1.70M$ -939.00K
Net Income Common Stockholders$ -5.74M$ -5.55M$ 12.84M$ -2.68M$ -1.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 40.32M$ 43.05M$ 51.18M$ 13.27M$ 12.40M
Total Assets$ 58.92M$ 63.16M$ 69.19M$ 26.86M$ 19.03M
Total Debt$ 29.78M$ 29.77M$ 29.75M$ 29.73M$ 24.72M
Net Debt$ -10.54M$ -13.29M$ -21.43M$ 16.46M$ 12.32M
Total Liabilities$ 64.09M$ 64.52M$ 66.18M$ 38.49M$ 29.56M
Stockholders Equity$ -5.17M$ -1.36M$ 3.01M$ -11.62M$ -10.53M
Cash Flow-
Free Cash Flow$ -2.21M$ -8.39M$ 39.05M$ -4.86M$ -2.76M
Operating Cash Flow$ -2.21M$ -8.39M$ 39.05M$ -4.86M$ -2.76M
Investing Cash Flow-----
Financing Cash Flow$ -528.00K$ 257.00K$ -1.13M$ 5.73M$ 201.00K
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Fennec Pharmaceuticals Debt to Assets

Fennec Pharmaceuticals Cash Flow

Fennec Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis